Partnership Tackles Lung Cancer, the No. 1 Cancer Killer Throughout the WorldContinue reading
Category Archives: AZBio News
HB2310 Recieves All Ayes in Senate HHS Committee
HB2310: biological products; prescription orders permits a pharmacist to substitute a biological product for a prescribed biological product if certain conditions are met, and outlines requirements relating to the substitution. HB2310 received a 6 -0-1 vote and Do Pass as Amended recommendation from the Senate Health and Human Services Committee on March 9, 2016. Read the Senate Fact Sheet. The next step in the process is review by the Senate Rules Committee.
Continue reading
HealthTell Raises $26M and Expands Scientific Advisory Board
HealthTell™, has raised $26M in new investment according to its latest filing with the SEC and expanded its Clinical Advisory Board with the additions of John Galgiani, M.D., and Chaim Putterman, M.D., as Clinical Advisors.Continue reading
PhRMA policy solutions for delivering innovative treatments to patients.
On March 10, 2016, the Pharmaceutical Research and Manufacturers of America (PhRMA) 2016 Annual Meeting, PhRMA president and CEO Stephen J. Ubl announced the association’s policy solutions for delivering innovative treatments to patients.Continue reading
Washington Update for March 2016
Each month, BIO provides the latest updates, issues and poll data on issues affecting our bioscience industry at the national level. Here’s what happened in February 2016.Continue reading
NuvOx Pharma Takes Top Honors at Venture Madness
NuvOx Pharma, a development stage pharmaceutical company based in Tucson, Arizona, beat out 63 other early stage contenders to take the winning spot at Venture Madness 2016.
Continue reading
BRAIN: Building Reliable Advances and Innovation in Neurotechnologies NSF Initiative Launches March 10 at Arizona State University
The BRAIN Center will develop safe, effective and affordable personalized neurotechnologies for diagnostics, restoration, enhancement, and rehabilitation of sensory, motor, affective and cognitive functions. This mission will be pursued by supporting innovative interdisciplinary research across the multiple dimensions of brain function and behavior with the ultimate goal of improving quality of life.
Continue reading
SynCardia releases early findings on 50cc temporary Total Artificial Heart
Early Findings of the 50cc SynCardia Heart Indicate That It Fits Underserved Patients – Women & AdolescentsContinue reading
Barrow neurosurgeon helps pave way for deep brain stimulation and Alzheimer’s
Neurosurgeons at Barrow Neurological Institute in Phoenix are involved with testing the viability of deep brain stimulation (DBS) to treat Alzheimer’s disease, a disorder that currently has few treatment options. Results from the Phase 2 study, reported in the Journal of Neurosurgery on
Dec. 18, 2015, demonstrated the safety of DBS in Alzheimer’s patients.Continue reading